Discovery of Prognostic Markers for Early-Stage High-Grade Serous Ovarian Cancer by Maldi-Imaging

With regard to relapse and survival, early-stage high-grade serous ovarian (HGSOC) patients comprise a heterogeneous group and there is no clear consensus on first-line treatment. Currently, no prognostic markers are available for risk assessment by standard targeted immunohistochemistry and novel a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kulbe, Hagen, Klein, Oliver, Wu, Zhiyang, Taube, Eliane T., Kassuhn, Wanja, Horst, David, Darb-Esfahani, Silvia, Jank, Paul, Abobaker, Salem, Ringel, Frauke, du Bois, Andreas, Heitz, Florian, Sehouli, Jalid, Braicu, Elena I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463791/
https://www.ncbi.nlm.nih.gov/pubmed/32707805
http://dx.doi.org/10.3390/cancers12082000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463791/
https://www.ncbi.nlm.nih.gov/pubmed/32707805
http://dx.doi.org/10.3390/cancers12082000

Ejemplares similares